Basal cell carcinoma with matrical differentiation: Expression of .-catenin and osteopontin

American Journal of Dermatopathology

Volumn 29, Issue 5, 2007, Pages 470-474

  Sordo, Rachele Del ^a   Cavaliere, Antonio ^a   Sidoni, Angelo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

catenin; Basal cell carcinoma with matrical differentiation; Osteopontin

Indexed keywords

CATENIN; OSTEOPONTIN;

AGED; ARTICLE; BASAL CELL CARCINOMA; BIOLOGICAL ACTIVITY; CASE REPORT; CELL DIFFERENTIATION; CELL STRUCTURE; DISEASE COURSE; FEMALE; GENE EXPRESSION; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

AGED; BETA CATENIN; CARCINOMA, BASAL CELL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HAIR FOLLICLE; HUMANS; MALE; OSTEOPONTIN; PILOMATRIXOMA; SKIN NEOPLASMS;

EID: 34648840094     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318156dceb     Document Type: Article

References (35)

1. Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathogical and molecular biological update. Br J Dermatol. 2003;148:195-202.
2. Elder D. Histology of the Skin. 8th ed. Philadelphia, Pa: JB Lippincott; 1997.
3. Aloi FG, Molinero A, Pippione M. Basal cell carcinoma with matrical differentation. Am J Dermatopathol. 1988;10:509-513.
4. Ambrojo P, Aguilar A, Simon P, et al. Basal cell carcinoma with matrical differentiation. Am J Dermatopathol. 1992;14:293-297.
5. Sagol Ö, Özer E. Basal cell carcinoma of the skin with matrical differentiation: a case report. East J Med. 1999;4:37-38.
6. Kwittken. Shadow cell basal cell carcinoma with acantholysis. Cutis. 2002;69:57-65.
7. Kim SH, Lee MG, Lee KG. Basal cell carcinoma with matrical differentiation. Yonsei Med J. 2003;44:523-525.
8. Haskell HD, Haynes HA, McKee PH, et al. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin. J Cutan Pathol. 2005;32:245-250.
9. Ali F, Brown A, Gottwald L, et al. Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature. J Cutan Pathol. 2005;32:445-448.
10. Yamazaki F, Aragane Y, Kawada A, et al. Immunohistochemical detection for nuclear β-catenin in sporadic basal cell carcinoma. Br J Dermatol. 2001;145:771-777.
11. Saldanha G, Ghura V, Potter L, et al. Nuclear β-catenin in basal cell carcinoma correlates with increased proliferation. Br J Dermatol. 2004;151:157-164.
12. Moreno-Bueno G, Gamallo C, Perez-Gallego L, et al. Beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutation and comparison with beta-catenin expression in normal hair follicles. Br J Dermatol. 2001;145:576-581.
13. Kajino Y, Yamaguchi A, Hashimoto N, et al. Beta-catenin gene mutation in human hair follicle-ralated tumors. Pathol Int. 2001;51:543-548.
14. Baron R, Rawadi G, Roman-Roman S. Wnt: a key regulator of bone mass. Curr Top Dev Biol. 2006;76:103-127.
15. Hirota S, Asada H, Kohri K, et al. Possible role of osteopontin in deposition of calcium phosphate in human pilomatricomas. J Invest Dermatol. 1995;105:138-142.
16. Jacobson M, Ackerman AB. Shadow cells as clues to follicular differentiation. Am J Dermatopathol. 1987;9:51-57.
17. Fanti PA, Varotti C, Tosti A. "Shadow" cells as clues to follicular differentiation. Am J Dermatopathol. 1988;9:51.
18. Ackerman AB. Basal cell carcinoma with follicular differentiation. Dr. Ackerman's response. Am J Dermatopathol. 1989;11:481-505.
19. Reed RJ, Lamar LM. Invasive hair matrix tumors of scalp. Arch Dermatol. 1966;94:310-316.
20. Rapini RP, Kennedy JS, Golitz LE. Hair matrix differentiation in condroid syringoma. J Cutan Pathol. 1984;11:318.
21. LeBoit PE, Parslow TG, Hoy SH. Hair matrix differentiation: occurrence in lesions other than pilomatrixoma. Am J Dermatopathol. 1987;9:399.
22. Cooper PH, Fechner RE. Pilomatricoma-like changes in the epidermal cysts of Gardner's syndrome. J Am Acad Dermatol. 1983;8:639.
23. Ackerman AB. Dr. Ackerman's reply. Am J Dermathopathol 1988;10:458-466.
24. Hardisson D, Linares MD, Cuevas-Santos J, et al. Pilomatrix carcinoma. A clinicopathologic study of six cases and a review of the literature. Am J Dermatopathol. 2001;23:394.
25. Mikhaeel NG, Spittle MF. Malignant pilomatrixoma with multiple local recurrences and distant metastases: a case report and review of the literature. Clin Oncol (R Coll Radiol). 2001;13:386.
26. Fuchs E, Merrill BJ, Jamora C, et al. At the roots of a never-ending cycle. Dev Cell. 2001;1:13.
27. Lazar AJF, Calonje E, Grayson W, et al. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding β-catenin. J Cutan Pathol. 2004;32:148-157.
28. Hassanein AM, Glanz SM. β-catenin expression in benign and malignant pilomatrix neoplasms. Br J Surg. 2004;150:511-516.
29. El-Bahrawy M, El-Masry N, Alison M, et al. Expression of beta-catenin in basal cell carcinoma. Br J Dermatol. 2003;148:964-970.
30. Tsuji H, Ishida-Yamamoto A, Takahashi H, et al. Nuclear localization of β-catenin in the hair matrix cells and differentiated keratinocytes. J Dermatol Sci. 2001;27:170-177.
31. Johnson RL, Rothaman A, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996;272:1668-1671.
32. Oro AE, Higgins KM, Hu Z, et al. Basal cell carcinoma in mice overexpressing sonic hedgehog. Science. 1997;276:817-821.
33. Boonchai W, Walsh M, Cummings M. Expression of β-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma. Arch Dermatol. 2000;136:937-938.
34. Fisher LW, Torchia DA, Fohr B, et al. Flexible structures of SIBLING proteins, bone sialoprotein and osteopontin. Biochem Biophys Res Commun. 2001;280:460-465.
35. Gorski JP. Acid phosphoprotein from bone matrix: a structural rationalization of their role in biomineralization. Calcif Tissue Int. 1992;50:391-396.